Recent Episodes
-
How Indegene Uses “Hybrid” Go-To-Market Model to Help Orchestra Omnichannel Pharma Launches for Their Clients
Jan 12, 2024 – 29:07 -
Greatest Hits: A Look Back on Five of the Best Pharma Launch Secrets Episodes
Sep 28, 2023 – 27:40 -
AI-Powered Compliant Content Creation at Scale: How Far Are We From Using Modular Content and Technology to Radically Transform Content Marketing in Pharma
Sep 13, 2023 – 36:06 -
“Professors in the Hot Seat,” Novo Nordisk, Medical Education, and Pharma Launches: How the KOL Interview Format Unleashed Repeated Engagement and Education for Novo Nordisk
Aug 30, 2023 – 30:34 -
US Launches: How to Use Media Channels, Ads, GPT, Endemic, and Non-Endemic Channels to Be Relevant From Day 1 and Drive a Successful Launch
Aug 16, 2023 – 37:43 -
Content, GPT, MLR, and Medical Affairs: How to Make Medical Operations Future-Ready and Lead with Trust, Scientific Evidence, and Omnichannel?
Aug 2, 2023 – 37:18 -
Medical Societies and Pharma: Unleashing Blockbuster Launches Through Partnerships and Medical Education
Jul 19, 2023 – 40:15 -
Binge-Worthy Content Experiences for HCPs: Why They Are the Key to Engaging HCPs in the Post-COVID World
Jul 5, 2023 – 42:59 -
Omnichannel and CDP (Customer Data Platforms): What Every Pharma Marketer Needs To Know About Using Data To Enable Seamless Customer Experience, Drive Engagement, And Lift Rx
Jun 21, 2023 – 45:34 -
A Conversation With The Havas Team: How to Use Omnichannel and CX to Succeed With Launches in 2023 and Beyond
Jun 7, 2023 – 39:48 -
Modular Content: How to Use It Effectively to Accelerate Pharma Launches and Drive HCP Behavior Change
May 24, 2023 – 39:48 -
Launching with Influencers: How to Leverage KOLs, DOLs and New Channels to Engage Healthcare Professionals Authentically During Your Product Launch
May 16, 2023 – 44:33 -
CX and Pharma Launches: Why Superior Clinical Data is Not Enough Anymore to Win Pharma Launches and How to Strategically Leverage Customer Experience
Apr 26, 2023 – 43:50 -
Omnichannel and Medical Affairs: What’s the Future?
Apr 12, 2023 – 37:40 -
23 Years Later: The Co-founder of Indegene Shares How Life Sciences Companies Reimagine Commercialization in 2023 in the Digital-First Reality
Mar 30, 2023 – 37:31 -
Launch Planning in a Digital-First Reality: How can a Traditional “Reach and Frequency” Model be Adapted to an Omnichannel Future?
Mar 15, 2023 – 43:13 -
The Power of Customer Experience: How Pharma Launches are Being Transformed, with Mark Makuch, SVP of Strategy at Havas Health CX
Mar 1, 2023 – 37:11 -
“Hidden Value” of Pharma Launches - Why All Pharma Companies Have It, How to Find It, and How to Leverage It
Feb 15, 2023 – 29:28 -
How Do Outdated FDA Regulations Affect the New World of Pharma Launches? With Dale Cooke, President of Philly Cooke Consulting
Feb 1, 2023 – 37:57 -
Bridging the “Pharma-Startup Gap”: How Can Pharma Companies and Digital-Health Startups Work Effectively to Bring Products to Market Faster
Dec 29, 2022 – 32:06 -
Search Listening: How One Billion Google Health Searches a Day Can Inform Pharma Launches with Julia Walsh, CEO of Brand Medicine International
Dec 21, 2022 – 38:11 -
How to Use Video Content to Engage HCPs: Secrets From Other Industries with Chris Savage, Co-founder and CEO of Wistia
Dec 7, 2022 – 31:38 -
Pharma’s NEW Launch Machine: How CX, Data, Multiple $200M - $500M Launches, and Agility Come Together with Indraneel Mukherjee, Senior Principal, Commercial Strategy at IQVIA Strategy Consulting
Nov 23, 2022 – 47:11 -
How to Use Video Content to Reach and Engage HCPs While Driving Product Adoption - Learnings From Other Industries with Tyler Lessard, VP of Marketing and Chief Video Strategist at Vidyard
Nov 9, 2022 – 40:47 -
First-in-Class vs Me-Too Launch Differences and the Role of Content, Hyperpersonalization, and Technology with Frank Dolan, Founder and CEO of ARSENAL
Oct 26, 2022 – 39:15 -
David and Goliath: How Can First-Time Launchers Avoid Failure and Beat Big Pharma Launches with Rohit Sood, Executive Vice President at EVERSANA
Oct 12, 2022 – 36:24 -
Peer-to-Peer Programs and Pharma Launches: Opportunities to Engage HCPs Using Short-Form, Trusted, Clinically Relevant Information with Andrew Willmer, EVP of Strategy and Innovation at Symbiotix
Sep 28, 2022 – 40:26 -
The Digital-First Future and the “Data flywheel”: How Can Pharma Use the Combination of Data, AI, and Content to Drive Successful Product Launches with Scott Snyder, Chief Digital Officer at EVERSANA
Sep 14, 2022 – 27:47 -
How Data Analytics Can Create Competitive Advantages for Your Pharma Launch with Bharti Rai, SVP and GM of Health Insights, Products and Solutions at CVS
Aug 31, 2022 – 33:36 -
US Launches: Right Size, Right Time, Right Place, and the Importance of Execution in Ensuring an Effective Launch with Trevor Landry, Senior Vice President - Commercial Lead at Syneos Health
Aug 3, 2022 – 26:32 -
Reuters Panel on Customer Engagement: How to Use Content to Drive HCP Trust
Jul 20, 2022 – 45:12 -
The Death of “Blockbuster” Products: Micro Launches and a Data-driven Approach to Marketing with Indraneel Mukherjee, Associate Partner at ZS Associates
Jul 6, 2022 – 36:41 -
Medical Affairs and Pharma Launches: Strategies, Budgeting and Planning with Meg Heim of Heim Global Consulting
Jun 21, 2022 – 29:48 -
Trust, Digital Innovation, Metaverse and Pharma Launches: What is the Connection? with Brendan Gallager of Publicis Health
Jun 21, 2022 – 31:00 -
EU Launches, Omnichannel and Medical Affairs: Beyond the Support Role, with Matthew Goodman of LUCENT biopharma
Jun 21, 2022 – 37:22 -
How to Use Personalized On-Demand Video to Engage HCPs. Bozidar Jovicevic, CEO of Evermed, Speaking at a Reuters Pharma Event
Jun 8, 2022 – 08:16 -
Trailer
May 13, 2022 – 01:05
Recent Reviews
-
BilmooreMust listen for Med Affairs!It was great to hear Meg Heim speaking about Medical Affairs planning and reframing cost as investment - love it
-
MDW-NYCOutstanding series. Actionable intel.Pharma launches are critical to the success and growth of companies large mid and small. They are very often make or break, and data show that more than 50% of launches fail to meet projections. This series offers global leaders speaking with Evermed CEO Dr Bozi Jovicevic, a 17-yr veteran of Novartis and Sanofi. Among the things you'll learn to understand better are the differences in launches in the US, EU, and JAPAC.
-
michaelreaderGreat IdeaPharma launch secrets is something that was missing in the market. It’s hard to find resources on this topic beyond classical IQVIA or McKinsey reports. Great idea.
Similar Podcasts
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.